Thus, this reduction of DRD3 expression in CD4+ T-cells obtained from PD patients could be interpreted as an adaptive down-regulation of this pro-inflammatory receptor after a long-term period of chronic inflammation in these patients. Here, DRD3 is linked to Parkinson disease.